BOUSSARD&GAVAUDAN LIMITED (EUR), : Transactions in Own Shares

BOUSSARD & GAVAUDAN HOLDING LIMITED
March 2023 TRANSACTION IN OWN SECURITIES REPORT¹

The Company announces that, pursuant the general authority granted by shareholders to market-purchase its Ordinary shares on 28/05/2019, it repurchased approximately 850 Euro shares in February 2023.

Figure of the March 2023 share buyback program

This transaction has resulted in the following:

31 March 2023

For more information, please contact:
Boussard & Gavaudan Investment Management, LLP

Emmanuel Gavaudan (London), +44 203 751 53989
François-Xavier Baud (London) +44 203 751 5395

The Company was established in the United States as an investment company with closed-end operations. Guernsey. The Guernsey Financial Services Commission has approved the Company and the States of Guernsey Policy Council. The Dutch Authority for the Financial Markets registered the Company as a collective investing scheme in accordance with article 2:73 and 2:66 of the Dutch Financial Supervision Act. financieel toezicht). The shares of the Company (the “Shares”) are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc’s main market for listed securities.

This is not an invitation to sell or solicitation of an offer to purchase securities in the United States or in any other country. This announcement does not intend to or constitute an invitation to purchase securities, solicitation of votes or approvals in any jurisdiction. Neither shall this announcement be used to sell, issue, transfer or transfer securities in any jurisdiction contrary to applicable law.

Neither the Company nor Boussard & Gavaudan Fund Plc has been, and neither will be, registered under the US Investment Company Act of 1940, as amended (the “Investment Company Act”). In In addition The securities mentioned in this announcement are not registered and will not be registered. US Securities Act of 33, as amended (the “Securities Act”) Accordingly These securities cannot be offered, sold, or transferred in the United States to or for the benefit of US citizens, except as required by the Securities Act or an exclusion therefrom, and under circumstances that don’t require the issuer to register under Investment Company Act. There will not be any public offering of securities in the United States.

Always remember that all investments are subject to change. risk;

1. Past results are not a guarantee for the future results;

2. The investment performance of BGHL could go down or up. You may not get back All of Your original investment.

3. You are strongly advised to seek professional financial advice if there are any questions regarding the content of this communication.

This communication is intended for informational purposes only. It should not be regarded as a replacement for professional advice or financial advice.

¹ This report contains transactions by both BGHL and Exane for the Liquidity Enhancement Agreement.

Attachment